My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Karyopharm Therapeutics Inc. - Common Stock (NQ:KPTI)

6.310 -0.350 (-5.26%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Karyopharm Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket ↗

September 02, 2022

Gainers

Via Benzinga

Karyopharm Therapeutics Earnings Perspective: Return On Capital Employed ↗

August 18, 2022

Via Benzinga

Karyopharm Therapeutics: Q2 Earnings Insights ↗

August 04, 2022

Karyopharm Therapeutics (NASDAQ:KPTI) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners ↗

July 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Analyst Ratings for Karyopharm Therapeutics ↗

May 05, 2022

Analysts have provided the following ratings for Karyopharm Therapeutics (NASDAQ:KPTI) within the last quarter:

Via Benzinga

Recap: Karyopharm Therapeutics Q1 Earnings ↗

May 05, 2022

Karyopharm Therapeutics (NASDAQ:KPTI) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 02, 2022

Tuesday's session saw 63 companies set new 52-week lows.

Via Benzinga

Karyopharm Shares Soar Following European Commission's Marketing Authorisation For Multiple Myeloma Candidate ↗

July 21, 2022

The European Commission (EC) has granted Marketing Authorisation for Karyopharm Therapeutics’ (NASDAQ: KPTI) lead candidate NEXPOVIO (selinexor) in combination with once-weekly bortezomib (Velcade) and...

Via Benzinga

Recap of Wednesday's Biotech Catalysts - End of The Day Summary ↗

July 20, 2022

Via Benzinga

Karyopharm Shares Soar On FDA Fast Track Status, EU Orphan Medicinal Product Status To Preleukemia Candidate ↗

July 20, 2022

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Karyopharm Therapeutics’ (NASDAQ: KPTI) lead asset Eltanexor as monotherapy for the treatment of patients with relapsed...

Via Benzinga

The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK ↗

June 16, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Karyopharm Therapeutics' Shares Slide After Biogen Terminates 2018 Asset Purchase Agreement ↗

June 15, 2022

Via Benzinga

Looking Into Karyopharm Therapeutics's Return On Capital Employed ↗

May 27, 2022

Karyopharm Therapeutics (NASDAQ:KPTI) brought in sales totaling $47.67 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 206.92%, resulting in a loss of $41.40...

Via Benzinga

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study ↗

May 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Karyopharm Therapeutics Earnings Preview ↗

May 04, 2022

Karyopharm Therapeutics (NASDAQ:KPTI) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

What 5 Analyst Ratings Have To Say About Karyopharm Therapeutics ↗

March 18, 2022

Over the past 3 months, 5 analysts have published their opinion on Karyopharm Therapeutics (NASDAQ:KPTI) stock. These analysts are typically employed by large Wall Street banks...

Via Benzinga

The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data ↗

March 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Mid-Afternoon Market Update: Dow Gains 2%; SAB Biotherapeutics Shares Slide ↗

March 02, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 2% on Wednesday. The Dow traded up 2.07% to 33,983.50 while the NASDAQ rose 1.77% to 13,771.67. The...

Via Benzinga

68 Biggest Movers From Yesterday ↗

March 03, 2022

Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 02, 2022

Gainers Trevi Therapeutics (NASDAQ:TRVI) shares rose 46.6% to $1.28 during Wednesday's regular session. As of 12:30 EST, Trevi Therapeutics's stock is trading at a...

Via Benzinga

41 Stocks Moving In Wednesday's Mid-Day Session ↗

March 02, 2022

Gainers ECMOHO Limited (NASDAQ: MOHO) jumped 67% to $0.3890 after jumping 10% on Tuesday. Nordstrom, Inc. (NYSE: JWN) shares jumped 38.7% to $27.11 after the company reported...

Via Benzinga

Mid-Day Market Update: Nasdaq Surges 150 Points; US Crude Oil Inventories Fall By 2.6M Barrels ↗

March 02, 2022

U.S. stocks extended gains midway through trading, with the Nasdaq index jumping 150 points on Wednesday. The Dow traded up 1.71% to 33,865.43 while the NASDAQ rose 1.11% to 13,...

Via Benzinga

Mid-Morning Market Update: U.S. Stocks Mixed; Dollar Tree Reports Mixed Q4 Results ↗

March 02, 2022

U.S. stocks opened mixed this morning, with the Dow Jones adding more than 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.66% to 33,513.04...

Via Benzinga

Where Karyopharm Therapeutics Stands With Analysts ↗

March 02, 2022

Karyopharm Therapeutics (NASDAQ:KPTI) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 02, 2022

Gainers IsoPlexis (NASDAQ:ISO) shares moved upwards by 22.8% to $5.5 during Wednesday's pre-market session. The company's market cap stands at $214.2 million. The...

Via Benzinga

The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi ↗

March 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Karyopharm Says FDA Mandates Additional Study For Expanding Selinexor Label...

Via Benzinga

Why Are Karyopharm Shares Trading Lower Today ↗

March 02, 2022

Karyopharm Therapeutics Inc (NASDAQ: KPTI) stock plunged after an update on its supplemental New Drug Application submission based on the Phase 3 SIENDO study data...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 02, 2022

Rise and shine, trader! It's time to start off another day of trading with the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

28 Stocks Moving in Wednesday's Pre-Market Session ↗

March 02, 2022

Gainers Guardion Health Sciences, Inc. (NASDAQ: GHSI) rose 46.4% to $0.4098 in pre-market trading after jumping around 48% on Tuesday. Guardion Health Sciences recently reported...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 01, 2022

Gainers Organogenesis Holdings (NASDAQ:ORGO

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.